Raymond Debbane

Raymond Debbane has an estimated net worth of $71.7 Million. This is based on reported shares across multiple companies, which include WW INTERNATIONAL, INC., eHealth, Inc., LEXICON PHARMACEUTICALS, INC., ANTIGENICS INC /DE/, Blue Buffalo Pet Products, Inc., Ceres, Inc., NITROMED INC, GLYCOMIMETICS INC, and Scholar Rock Holding Corp.

2019 was Raymond Debbane's most active year for acquiring shares with 58 total transactions. Raymond Debbane's most active month to acquire stocks was the month of August. 2024 was Raymond Debbane's most active year for disposing of shares, totalling 16 transactions. Raymond Debbane's most active month to dispose stocks was the month of July. 2008 saw Raymond Debbane paying a total of $206,820,552.39 for 51,505,738 shares, this is the most they've acquired in one year. In 2024 Raymond Debbane cashed out on 4,288,964 shares for a total of $82,886,387.88, their largest year based on trade value.